HK1218139A1 - 去分化的重新編程細胞所衍生的細胞組合物 - Google Patents

去分化的重新編程細胞所衍生的細胞組合物 Download PDF

Info

Publication number
HK1218139A1
HK1218139A1 HK16106057.9A HK16106057A HK1218139A1 HK 1218139 A1 HK1218139 A1 HK 1218139A1 HK 16106057 A HK16106057 A HK 16106057A HK 1218139 A1 HK1218139 A1 HK 1218139A1
Authority
HK
Hong Kong
Prior art keywords
cell compositions
reprogrammed cells
compositions derived
cell culture
dedifferentiated reprogrammed
Prior art date
Application number
HK16106057.9A
Other languages
English (en)
Chinese (zh)
Inventor
Alan D. Agulnick
Olivia Kelly
Yuki OHI
Allan Robins
Thomas Schultz
Original Assignee
Viacyte, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/761,078 external-priority patent/US9109245B2/en
Application filed by Viacyte, Inc. filed Critical Viacyte, Inc.
Publication of HK1218139A1 publication Critical patent/HK1218139A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012—Cell encapsulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK16106057.9A 2013-02-06 2014-02-06 去分化的重新編程細胞所衍生的細胞組合物 HK1218139A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/761,078 2013-02-06
US13/761,078 US9109245B2 (en) 2009-04-22 2013-02-06 Cell compositions derived from dedifferentiated reprogrammed cells
PCT/US2014/015156 WO2014124172A1 (en) 2013-02-06 2014-02-06 Cell compositions derived from dedifferentiated reprogrammed cells

Publications (1)

Publication Number Publication Date
HK1218139A1 true HK1218139A1 (zh) 2017-02-03

Family

ID=50239931

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16106057.9A HK1218139A1 (zh) 2013-02-06 2014-02-06 去分化的重新編程細胞所衍生的細胞組合物

Country Status (8)

Country Link
EP (1) EP2954045A1 (https=)
JP (5) JP6517702B2 (https=)
AU (5) AU2014214879A1 (https=)
CA (2) CA3212301A1 (https=)
HK (1) HK1218139A1 (https=)
IL (5) IL311689B2 (https=)
RU (2) RU2675928C2 (https=)
WO (1) WO2014124172A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9109245B2 (en) 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
AU2015300020B2 (en) 2014-08-04 2021-04-08 Orizuru Therapeutics, Inc. Method for proliferation of pancreatic progenitor cells
DK3443073T3 (da) * 2016-04-14 2024-09-02 Janssen Biotech Inc Differentiering af pluripotente stamceller til intestinale mellemtarmendodermceller
CN111334463B (zh) * 2016-05-18 2024-02-20 学校法人庆应义塾 类器官培养用细胞培养基、培养方法及类器官
EP3587560A4 (en) 2017-01-27 2020-12-16 Kaneka Corporation Endodermal cell mass, and method for producing any one of three primary germ layer cell mass from pluripotent cells
CN111565707A (zh) 2017-06-14 2020-08-21 森玛治疗公司 用于递送治疗物的装置和方法
EP3654996A4 (en) * 2017-07-21 2021-03-24 Semma Therapeutics, Inc. REAGGREGATION OF PANCREAS BETA CELLS FROM STEM CELLS
US20210292708A1 (en) * 2018-08-03 2021-09-23 Kyoto University Cell production method
BR112021004815A2 (pt) * 2018-09-19 2021-06-01 Takeda Pharmaceutical Company Limited células produtoras de insulina, medicamento, e, métodos para produzir células produtoras de insulina, para gerar células do tipo ilhota pancreática, para tratar diabetes mellitus, para melhorar e/ou manter o controle dos níveis de glicose em jejum e pós-prandial em um paciente e para reduzir o risco de hipoglicemia em um paciente com diabetes mellitus
WO2020243665A1 (en) 2019-05-31 2020-12-03 W. L. Gore & Associates, Inc. A biocompatible membrane composite
WO2020243666A1 (en) 2019-05-31 2020-12-03 W. L. Gore & Associates, Inc. A biocompatible membrane composite
AU2020282355B2 (en) 2019-05-31 2023-11-02 Viacyte, Inc. A biocompatible membrane composite
CN114401752B (zh) 2019-05-31 2023-04-04 W.L.戈尔及同仁股份有限公司 具有受控氧扩散距离的细胞封装装置
IL300105A (en) 2020-07-31 2023-03-01 Vertex Pharma Pancreatic endocrine cell differentiation
CN119948151A (zh) * 2022-09-26 2025-05-06 国立大学法人京都大学 胰腺内胚层细胞的制造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE397959T1 (de) * 1999-04-06 2008-07-15 Genentech Inc Verwendung von erbb-rezeptorliganden zur behandlung von diabetes
US6759039B2 (en) * 2000-06-30 2004-07-06 Amcyte, Inc. Culturing pancreatic stem cells having a specified, intermediate stage of development
CA2435826A1 (en) * 2001-01-24 2002-08-01 The Government Of The United States Of America Differentiation of stem cells to pancreatic endocrine cells
CN101310012B (zh) * 2005-10-14 2012-05-09 明尼苏达大学董事会 非胚胎干细胞分化成具有胰腺表型的细胞
AU2007254766A1 (en) * 2006-06-02 2007-12-13 University Of Georgia Research Foundation, Inc. Pancreatic and liver endoderm cells and tissue by differentiation of definitive endoderm cells obtained from human embryonic stems
AU2009313870B2 (en) 2008-11-14 2013-07-11 Viacyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
US9109245B2 (en) * 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
US20100272695A1 (en) * 2009-04-22 2010-10-28 Alan Agulnick Cell compositions derived from dedifferentiated reprogrammed cells
US8685726B2 (en) * 2009-04-27 2014-04-01 Viacyte, Inc. Small molecules supporting pluripotent cell growth and methods thereof
EP2436397B1 (en) * 2009-05-29 2017-05-10 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition containing antagonist of egf family ligand as component

Also Published As

Publication number Publication date
RU2018144412A (ru) 2019-03-25
JP6721752B2 (ja) 2020-07-15
JP2016506736A (ja) 2016-03-07
JP7250731B2 (ja) 2023-04-03
IL283088A (en) 2021-06-30
IL290717B1 (en) 2024-06-01
IL290717A (en) 2022-04-01
EP2954045A1 (en) 2015-12-16
IL311689A (en) 2024-05-01
AU2022200075A1 (en) 2022-02-03
JP2020178694A (ja) 2020-11-05
AU2023202507B2 (en) 2025-12-04
RU2675928C2 (ru) 2018-12-25
AU2023202507A1 (en) 2023-05-11
AU2022200075B2 (en) 2023-02-02
IL239953A0 (en) 2015-08-31
IL311689B2 (en) 2025-12-01
AU2019201314A1 (en) 2019-03-14
WO2014124172A1 (en) 2014-08-14
AU2019201314B2 (en) 2021-10-14
CA3212301A1 (en) 2014-08-14
IL311689B1 (en) 2025-08-01
JP6517702B2 (ja) 2019-05-22
AU2022200075C1 (en) 2023-07-06
RU2018144412A3 (https=) 2020-02-14
IL321825A (en) 2025-08-01
AU2026201562A1 (en) 2026-03-19
RU2754089C2 (ru) 2021-08-26
JP2025000625A (ja) 2025-01-07
JP2019146578A (ja) 2019-09-05
RU2015131279A (ru) 2017-03-13
CA2898431C (en) 2023-10-17
AU2014214879A1 (en) 2015-07-30
IL290717B2 (en) 2024-10-01
IL283088B (en) 2022-04-01
CA2898431A1 (en) 2014-08-14
JP2023017838A (ja) 2023-02-07
JP7550830B2 (ja) 2024-09-13
IL239953B (en) 2021-05-31

Similar Documents

Publication Publication Date Title
HK1218139A1 (zh) 去分化的重新編程細胞所衍生的細胞組合物
IL273159A (en) A culture medium preparation, and a method for culturing cells or tissues by using the preparation
WO2010124142A3 (en) Cell compositions derived from dedifferentiated reprogrammed cells
MX375786B (es) Biosintesis microbiana de ergotioneina.
WO2016012544A3 (en) Enhanced reprogramming to ips cells
UA118328C2 (uk) Спосіб інтегрування екзогенних послідовностей у геном рослинної клітини
WO2012006440A3 (en) Endothelial cell production by programming
WO2012051210A3 (en) Mesenchymal stem cells and related therapies
EP2904103B8 (en) Method for preparing induced pluripotent stem cells and its applications
MY169357A (en) Methods for additive manufacturing of implant components
MY170720A (en) Antibody formulations
EP3060650A4 (en) Culturing pluripotent stem cells
WO2011130402A3 (en) Hepatocyte production by forward programming
MX2019003427A (es) Composiciones para cultivo celular y metodos para la produccion de polipeptidos.
HK1222205A1 (zh) 由多能干细胞产生的光感受器和光感受器袓细胞
AU2016250905A8 (en) Generation of muscle-lineage cells from stem cells
AU2013225816A8 (en) Compositions and methods for treating Type III Gaucher Disease
SG10201809452RA (en) Cell culture compositions with antioxidants and methods for polypeptide production
WO2012019002A3 (en) Somatic stem cells
EP3048169A4 (en) Method for preparing pluripotent stem cells
MX366112B (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
EP3263697A4 (en) Culture medium for culturing mesenchymal stem cell, method for culturing mesenchymal stem cell, and mesenchymal stem cell
WO2013188469A3 (en) Pathways characterization of cells
WO2014027176A3 (en) Stem cell culture method
WO2013163297A8 (en) Modified glycoproteins